Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Colossal Biosciences
AddedFeb 13, 2024
UpdatedJun 18, 2026
Colossal Biosciences

Colossal Biosciences

Series A

Colossal Biosciences: A biotech firm reviving extinct species like the woolly mammoth and Tasmanian tiger.

HQ
Austin, TX, US
Founded
2021
Overview
Compare
Fundraising
Employees
News
Website

Colossal Biosciences, founded with the mission to leverage genetic engineering for de-extinction, aims to revive species like the woolly mammoth, Tasmanian tiger, and dodo. The company envisions reintroducing these species into their natural habitats to restore ecological balance. Their primary focus is on developing hybrid calves of the woolly mammoth by 2028 and launching a thylacine research project to release Tasmanian tiger joeys in Australia. Colossal's innovative approach combines cutting-edge biotechnology with conservation efforts.

Notable figures associated with Colossal Biosciences include prominent geneticists and conservationists who bring expertise and credibility to their ambitious projects. The company has garnered significant attention and investment from leading venture capitalists and biotech investors, underscoring its potential impact. Key achievements include advancements in genetic engineering techniques and successful initial phases of their de-extinction projects. Colossal Biosciences aims to make a profound ecological impact by reviving extinct species and promoting biodiversity.

Colossal Biosciences - Similar Companies

Mammoth Biosciences logo

Mammoth Biosciences

eGenesis logo

eGenesis

egenesisbio.com

Altos Labs logo

Altos Labs

altoslabs.com

Sylvatica Biotech logo

Sylvatica Biotech

sylvaticabio.com

Fauna Bio logo

Fauna Bio

faunabio.com

TigerGene logo

TigerGene

CasTag Biosciences logo

CasTag Biosciences

Convalesce logo

Convalesce

convalesce.co

BioViva logo

BioViva

Recombinetics logo

Recombinetics

recombinetics.com

Retro Biosciences logo

Retro Biosciences

retro.bio

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Rejuvenate Bio logo

Rejuvenate Bio

rejuvenatebio.com

Innovative Genetics logo

Innovative Genetics

Ginkgo Bioworks logo

Ginkgo Bioworks

ginkgobioworks.com

Colossal Biosciences - Quick Facts

Who are Colossal Biosciences' competitors?

Companies similar to Colossal Biosciences include Mammoth Biosciences, eGenesis, Altos Labs and Sylvatica Biotech.

When was Colossal Biosciences founded?

Colossal Biosciences was founded in 2021.

Where is Colossal Biosciences' headquarters located?

Colossal Biosciences' headquarters is located in Austin, TX, US.

When was Colossal Biosciences' last funding round?

Colossal Biosciences' most recent funding round was for $10.5M (USD) in November 2023.

How much has Colossal Biosciences raised to-date?

As of Nov 13, 2023, Colossal Biosciences has raised a total of $235.5M (USD).

How many employees does Colossal Biosciences have?

Colossal Biosciences has 165 employees as of Feb 5, 2024.

Colossal Biosciences - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Genetic Engineering
Tags
  • Consulting
  • GenAI
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified